or Try an Advanced Search...

    Technical Analysis for AVIR - Atea Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    C 3.93 -0.25% -0.01
    AVIR closed down 0.25 percent on Wednesday, May 8, 2024, on 41 percent of normal volume. It was able to find support at its 50 day moving average. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    3 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical AVIR trend table...
    Date Alert Name Type % Chg
    Stochastic Sell Signal Bearish 0.00%
    50 DMA Support Bullish 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Gapped Down Weakness 0.00%
    Bearish Engulfing Bearish -0.25%
    50 DMA Support Bullish -0.25%
    MACD Bullish Centerline Cross Bullish -0.25%
    Upper Bollinger Band Walk Strength -0.25%
    Earnings Movers Other -0.25%
    Older End-of-Day Signals for AVIR ...

       Recent Intraday Alerts

    Alert Time
    50 DMA Support about 12 hours ago
    60 Minute Opening Range Breakout about 12 hours ago
    Possible NR7 about 13 hours ago
    Down 2 % about 17 hours ago
    Fell Below 50 DMA about 18 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    AVIR Chart by TradingView
    Basic chart:

    Profile

    Atea Pharmaceuticals, Inc. is a clinical stage company, which focuses on discovering, developing, and commercializing antiviral therapeutics. Its product pipelines include Coronaviridae, Flaviviridae, and Paramyxovirdae. The company was founded by Jean-Pierre Sommadossi and David Chu in July 2012 and is headquartered in Boston, MA.
    Classification
    Sector: Healthcare
    Industry: Biotechnology

    Is AVIR a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 7 Atea Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call on May 14, 2024
    Apr 29 Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024
    Mar 27 Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients
    Feb 29 Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) Q4 2023 Earnings Call Transcript
    Feb 29 Atea Pharmaceuticals, Inc. (AVIR) Q4 2023 Earnings Call Transcript
    Feb 29 Atea Pharmaceuticals, Inc. 2023 Q4 - Results - Earnings Call Presentation
    Feb 28 Atea Pharmaceuticals Inc (AVIR) Announces Q4 and Full Year 2023 Financial Results
    Feb 28 Atea Pharmaceuticals GAAP EPS of -$0.47 beats by $0.03
    Feb 28 Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
    Feb 21 Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
    See more AVIR news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.19
    52 Week Low 2.765
    Average Volume 311,679
    200-Day Moving Average 3.48
    50-Day Moving Average 3.91
    20-Day Moving Average 3.78
    10-Day Moving Average 3.83
    Average True Range 0.12
    RSI (14) 56.52
    ADX 18.62
    +DI 24.39
    -DI 14.02
    Chandelier Exit (Long, 3 ATRs) 3.64
    Chandelier Exit (Short, 3 ATRs) 4.01
    Upper Bollinger Bands 3.98
    Lower Bollinger Band 3.58
    Percent B (%b) 0.86
    BandWidth 10.67
    MACD Line 0.02
    MACD Signal Line -0.02
    MACD Histogram 0.037
    Fundamentals Value
    Market Cap 327.9 Million
    Num Shares 83.4 Million
    EPS -1.57
    Price-to-Earnings (P/E) Ratio -2.50
    Price-to-Sales 1.90
    Price-to-Book 0.61
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.05
    Resistance 3 (R3) 4.04 3.99 4.03
    Resistance 2 (R2) 3.99 3.96 3.99 4.03
    Resistance 1 (R1) 3.96 3.94 3.97 3.97 4.02
    Pivot Point 3.91 3.91 3.91 3.91 3.91
    Support 1 (S1) 3.88 3.87 3.89 3.89 3.84
    Support 2 (S2) 3.82 3.86 3.83 3.83
    Support 3 (S3) 3.80 3.82 3.83
    Support 4 (S4) 3.81